Short Courses*

Our short courses are designed to be instructional, interactive and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during our main presentations.

PRE-CONFERENCE SHORT COURSES* | MONDAY, SEPTEMBER 16 | 2:00 - 5:00 PM

SC1: Immunology Basics
Instructor: Thomas Sundberg, PhD, Senior Research Scientist I, Center for Development of Therapeutics, Broad Institute of MIT and Harvard

SC2: Targeting of Ion Channels with Monoclonal Antibodies
Instructor: Trevor Wilkinson, PhD, Associate Director, Antibody Discovery and Protein Engineering, AstraZeneca, United Kingdom

SC3: Selection, Screening and Engineering for Affinity Reagents
Instructors: Jonas V. Schaefer, PhD, Laboratory Head, Novartis Institutes for BioMedical Research (NIBR), Switzerland
Additional Instructor to be Announced, MorphoSys AG, Switzerland

SC4: How to Best Utilize 3D Cells, Spheroids and PDX Models in Oncology
Instructors: Madhu Lal-Nag, PhD, Office of Translational Sciences, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
Geoffrey Bartholomeusz, PhD, Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

SC5: Applications of Artificial Intelligence and Machine Learning in Drug Discovery and Development
Instructor: Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan 
Additional Instructors to be Announced

SC6: Biochemistry and Pharmacology of the Ubiquitin-Proteasome System
Instructor: Alexander Statsyuk, PhD, Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

DINNER SHORT COURSES* | WEDNESDAY, SEPTEMBER 18 | 7:00 - 9:30 PM

SC8: GPCR Structure-Based Drug Discovery 
Instructor: Huixian Wu, PhD, Principal Scientist, Structural and Molecular Sciences, Discovery Sciences, Pfizer, Inc.

SC9: Targeted Protein Degradation Using PROTACs, Molecular Glues and More
Instructors: Alexander Statsyuk, PhD, Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston
James Robinson, PhD, Associate Principal Scientist, Discovery Sciences, AstraZeneca
Additional Instructors to be Announced

 

*Separate registration required

* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2019/04/18
Event Information updated



Premier Sponsors

AbCellera
Ablexis Alivamab_stacked

Eurofins

Integral

OmniAb Ligand_Pharmaceuticals